About Jellagen
Jellagen is a company based in Pembroke Dock (United Kingdom) founded in 2013 by Alex Paul Muhlholzl.. Jellagen has raised $21.28 million across 6 funding rounds from investors including Newable, Development Bank of Wales and Thai Union Group. The company has 13 employees as of December 31, 2020. Jellagen offers products and services including Collagen Type 0, Wound Repair Application, Bone Repair Application, Cartilage Repair Application, and Implantable Devices. Jellagen operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Pembroke Dock, United Kingdom
- Employees 13 as on 31 Dec, 2020
- Founders Alex Paul Muhlholzl
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Jellagen Limited
- Date of Incorporation 29 May, 2013
- Jurisdiction STIRLING
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$21.28 M (USD)
in 6 rounds
-
Latest Funding Round
$10.6 M (USD), Series A
Dec 07, 2022
-
Investors
Newable
& 5 more
-
Employee Count
13
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Jellagen
Jellagen offers a comprehensive portfolio of products and services, including Collagen Type 0, Wound Repair Application, Bone Repair Application, Cartilage Repair Application, and Implantable Devices. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Collagen for advanced wound and tissue healing in medicine
Solution for healing wounds using collagen-based innovation
Collagen for bone regeneration in regenerative medicine
Biomaterial aiding cartilage repair and tissue engineering
Collagen-based devices for in-vivo medical applications
Unlock access to complete
Unlock access to complete
Funding Insights of Jellagen
Jellagen has successfully raised a total of $21.28M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $10.6 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $10.6M
-
First Round
First Round
(01 Apr 2014)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Series A - Jellagen | Valuation | Thai Union Group , Cardiff Capital Region | |
| Jul, 2020 | Amount | Seed - Jellagen | Valuation |
investors |
|
| Apr, 2018 | Amount | Seed - Jellagen | Valuation | Newable , Development Bank of Wales |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Jellagen
Jellagen has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Newable, Development Bank of Wales and Thai Union Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of equity funding and business & property development loans
|
Founded Year | Domain | Location | |
|
Seafood products are distributed globally by Thai Union Group.
|
Founded Year | Domain | Location | |
|
Partnership of councils fostering innovation, investment, and inclusive growth in South East Wales.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Jellagen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Jellagen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Jellagen Comparisons
Competitors of Jellagen
Jellagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Jellagen
Frequently Asked Questions about Jellagen
When was Jellagen founded?
Jellagen was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Jellagen located?
Jellagen is headquartered in Pembroke Dock, United Kingdom. It is registered at Pembroke Dock, Pembrokeshire, United Kingdom.
Who is the current CEO of Jellagen?
Thomas-Paul Descamps is the current CEO of Jellagen.
Is Jellagen a funded company?
Jellagen is a funded company, having raised a total of $21.28M across 6 funding rounds to date. The company's 1st funding round was a Seed of $5.24M, raised on Apr 01, 2014.
How many employees does Jellagen have?
As of Dec 31, 2020, the latest employee count at Jellagen is 13.
What does Jellagen do?
Provider of medical-grade collagen type for life science researchh. It offers Collagen Type 0 is a medical-grade collagen derived from jellyfish species, including Rhizostoma pulmo. It has applications in tissue engineering and regenerative medicine.
Who are the top competitors of Jellagen?
Jellagen's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Jellagen offer?
Jellagen offers Collagen Type 0, Wound Repair Application, Bone Repair Application, Cartilage Repair Application, and Implantable Devices.
Who are Jellagen's investors?
Jellagen has 6 investors. Key investors include Newable, Development Bank of Wales, Thai Union Group, Cardiff Capital Region, and Development Bank of Wales.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.